Disease Info
Education & Teaching
Federal Government
International Society
Journals & Articles
Meetings
Policy
Professional Society
Private & Support
Regional Genetics 
Research & Grants
State Genetics

Policy

American Academy of Pediatrics (Committee on Genetics)

  • Health Supervision for Children with Turner Syndrome
  • Health Supervision for Children with Neurofibromatosis
  • Newborn Screening Fact Sheets
  • Health Supervision for Children with Sickle Cell Diseases and Their Families
  • Health Supervision for Children with Down Syndrome
  • Prenatal Genetic Diagnosis for Pediatricians
  • Folic Acid for the Prevention of Neural Tube Defects
  • Health Supervision for Children with Achondroplasia
  • Health Supervision for Children with Fragile X Syndrome
  • Health Supervision for Children with Marfan Syndrome
  • Maternal Phenylketonuria
  • Issues in Newborn Screening
  • Newborn Screening for Congenital Hypothyriodism: Recommended Guidelines

American Academy of Pediatrics (Committee on Children with Disabilities)

  • General Principles in the Care of Children and Adolescents with Genetic Disorders and Other Chronic Health Conditions

American College of Medical Genetics

  • Prenatal Interphase Fluorescence In Situ Hybridization (FISH) Policy Statement
  • ACMG Position Statement on Multiple Marker Screening in Women 35 and Older
  • Fragile X Syndrome: Diagnostic and Carrier Testing
  • Statement on Storage and Use of Genetic Materials
  • Statement on Multiple Marker Screening in Pregnant Women
  • Statement on Nutritional Supplements and Piracetam for Children with Down Syndrome
  • Statement on Guidance for Genetic Counseling in Advanced Paternal Age
  • Statement on Use of Apolipoprotein E Testing for Alzheimer Disease
  • ASHG/ACMG Report: Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
  • Diagnostic Testing for Prader-Willi and Angelman Syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee
  • Folic Acid and Pregnancy
  • Statement on Population Screening for BRCA-1 Mutation in Ashkenazi Jewish Women
  • Principles of Screening: Report of the Subcommittee on Screening of the American College of Medical Genetics Clinical Practice Committee
  • Statement on Folic Acid: Fortification and Supplementation
  • Position Statement on Carrier Testing for Canavan Disease
  • Statement on Genetic Testing for Cystic Fibrosis

American College of Obstetrics and Gynecologists (ACOG): (Committee on Genetics)

  • Current Status of Cystic Fibrosis Carrier Screening: MISSING FROM LIBRARY’s ACOG BINDER (OUT OF PRINT)
  • Chorionic Villus Sampling
  • Fragile X Syndrome
  • Screening for Tay-Sachs Disease
  • Genetic Screening for Hemoglobinopathies
  • Breast-Ovarian Cancer Screening: MISSING FROM LIBRARY’s ACOG BINDER (OUT OF PRINT)
  • Genetic Evaluation of Stillbirths and Neonatal Deaths: MISSING FROM LIBRARY’s ACOG BINDER (OUT OF PRINT)
  • Routine Storage of Umbilical Cord Blood for Potential Future Transplantation
  • Advanced Paternal Age: Risks to the Fetus
  • Genetic Screening of Game Donors
  • Screening for Canavan Disease (MISSING FROM LIBRARY’s ACOG BINDER: ALSO AVAILABLE at Obset Gynecol Vol 92, No 5, at bindery until 6/20/99)

American College of Rheumatology (Council on Research)

  • Position Statement: Fetal Tissue Research

American Medical Association (Council on Ethical and Judicial Affairs)

  • Multiplex Genetic Testing
  • Genetic Testing of Children
  • Genetics Testing Legislation
  • Human Genome Project
  • Patenting the Human Genome
  • Gene Therapy
  • Genetic Counseling
  • Genetic Engineering
  • Genetic Testing by Employers
  • Insurance Companies and Genetic Information
  • Ethical Issues in Carrier Screening of Genetic Disorders
  • In Vitro Fertilization
  • Frozen Pre-Embryos
  • Pre-Embryo Splitting

American Public Health Association

  • Guidelines for Genetic Testing in Industry
  • Maternal Serum Alpha-Fetoprotein Screening
  • Bioproducts Released into the Environment
  • Regulation of Foods Derived from Genetically Engineered Plants
  • Genetics and Public Health
  • Preventing Birth Defects from Maternal Phenylketonuria

American Society of Clinical Oncology (Subcommittee on Genetic Testing for Cancer Susceptibility)

  • Genetic Testing for Cancer Susceptibility

American Society of Human Genetics

  • 1994 ASHG Presidential Address: Who Are We? Where Are We Going? Anticipating the 21st Century
  • Policy Statement for Maternal Serum Alpha-Fetoprotein Screening Programs and Quality Control for Laboratories Performing Maternal Serum and Amniotic Fluid Alpha-Fetoprotein Assays
  • DNA Banking and DNA Analysis: Points to Consider
  • Proposed ASHG Position on Mapping/Sequencing the Human Genome
  • Update on MSAFP Policy Statement from the American Society of Human Genetics
  • ASHG Statement on Cystic Fibrosis Screening
  • ASHG Social Issues Committee Report on Genetics and Adoption: Points to Consider
  • ASHG Statement on Clinical Genetics and Freedom of Choice
  • ASHG Position Paper on Patenting of Expressed Sequence Tags
  • ASHG Human Genome Committee Report: The Human Genome Project: Implications for Human Genetics
  • Statement of the ASHG on Cystic Fibrosis Carrier Screening
  • Statement of the ASHG on Genetic Testing for Breast and Ovarian Cancer Predisposition
  • Genetic Testing and Insurance
  • Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
  • Statement on Use of Apolipoprotein E Testing for Alzheimer Disease
  • Statement on Informed Consent for Genetic Research
  • Recent Developments in Human Behavioral Genetics: Past Accomplishments and Future Directions
  • Professional Disclosure of Familial Genetic Information
  • Eugenics and the Misuse of Genetic Information to Restrict Reproductive Freedom
  • Response to National Bioethics Advisory Commission of the Ethical Issues and Policy Concerns Surrounding Research Using Human Biological Materials
  • Background Statement: Genetic Testing and Insurance (The Ad Hoc Committee on Genetic Testing/Insurance Issues)

Association of State and Territorial Health Officials

  • Policy Positions (October 1998): 50 page document, not directly on genetics

Council of State and Territorial Epidemiologists

  • Requested all 1998 position statements (not here yet)

Institute of Medicine

  • Assessing Genetic Risks: Implications for Health and Social Policy: Executive Summary

National Society of Genetic Counselors

Position Statements on:

  • Access to Care
  • Nondiscrimination
  • Confidentiality of Test Reports
  • Disclosure and Informed Consent
  • Cystic Fibrosis Screening
  • Genetic Screening

Resolutions on:

  • Reproductive Freedom
  • Prenatal Substance Abuse
  • Fetal Tissue Research
  • National Health Care Reform
  • Prenatal and Childhood Testing for Adult-Onset Disorders

Code of Ethics:

  • Section 1: Genetic Counselors Themselves
  • Section 2: Genetic Counselors and Their Clients
  • Section 3: Genetic Counselors and Their Colleagues
  • Section 4: Genetic Counselors and Society

Wertz and Fletcher (a statement by two professionals…not an organizational statement)

  • Proposed: An International Code of Ethics for Medical Genetics

Working Group on Ethical Issues in Umbilical Cord Banking

  • Consensus Statement: Ethical Issues in Umbilical Cord Blood Banking

PRIVATE/SUPPORT ORGANIZATIONS

American Heart Association

  • Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Lont-QT Syndrome, and Marfan Syndrome

Association of Retarded Citizens (ARC): Reports of the ARC’s Human Genome Education Project

  • An introduction to Genetics and Mental Retardation
  • Genetic Discrimination: Why Should We Care?
  • Genetic Testing, Screening, and Counseling: An Overview
  • Protecting Genetic Privacy

Council for Responsible Genetics (CRG)

  • Position Statement on Genetic Discrimination
  • A Proposed Model Law to Prevent Genetic Discrimination

Foundation on Economic Trends

  • Proposed Amendment to the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to Establish a Public Policy Advisory Committee
  • Petition to Amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to Establish a Public Policy Advisory Committee

Hereditary Disease Foundation

  • Statement on Protection Against Genetic Discrimination

Huntington’s Disease Society of America, Inc.

  • Guidelines for Genetic Testing for Huntington’s Disease

Little People of America

  • Position Statement on Genetic Discoveries in Dwarfism

National Action Plan on Breast Cancer (NAPBC)

  • (See also federal government section: NIH-DOE ELSI Working Group and NAPBC)
  • NAPBC National Biological Resource Banks Working Group Sunset Report (July 1998)
  • NAPBC Biological Resource Working Group Editorial Response to "Guardians of the Wax…and the Patient." Modern Pathology, 8(7): 699-700.
  • Consent Form for Use of Tissue for Research
  • How is Tissue Used for Research?
  • Recommendations on Genetic Information and the Workplace
  • Position Paper: Hereditary Susceptibility Testing for Breast Cancer

National Action Plan on Breast Cancer (NAPBC)

Public Responsibility in Medicine and Research (PRIM&R)

Applied Research Ethics National Association (ARENA)

National Cancer Institute (NCI)

NIH Office of Research on Women’s Health (ORWH)

  • Informed Consent and IRB Review: A Model for Review and Discussion

National Down Syndrome Congress

  • Position Statement of the National Down Syndrome Congress on Prenatal Testing and Eugenics: Families’ Rights and Needs

National Hemophilia Foundation

  • Statement of the National Hemophilia Foundation Concerning the Easing of Restrictions, Relating to Creutzfeldt-Jakob Disease, on Albumin and Albumin as an Excipient
  • Press Release: NHF Opposes New CJD Policy for Blood Supply
  • Statement on the Availability and Safety of Plasma Products

National Neurofibromatosis Foundation (Clinical Care Advisory Board)

  • The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2

United Methodist Church’s General Board of Church and Society

  • Religious Leaders Oppose Patenting Genes and Animals

INTERNATIONAL SOCIETIES

Alzheimer’s Disease International (Medical and Scientific Advisory Committee)

  • Consensus Statement on Predictive Testing for Alzheimer Disease

Australian National Health and Medical Research Council (from Brody: The Ethics of Biomedical Research)

  • Statement on Human Experimentation and Supplementary Notes (see Supplementary Note 7: Somatic Cell Gene Therapy and Other Forms of Experimental Introduction of DNA and RNA into Human Subjects)

British Committee on the Ethics of Gene Therapy (from Brody: The Ethics of Biomedical Research)

  • Summary of Main Conclusions and Recommendations on the Ethics of Gene Therapy (1989)

British Society for Human Genetics

  • Co-ordinated Arrangements for Genetic Testing for Rare Disorders
  • The Genetic Testing of Children: Report of a Working Party of the Clinical Genetics Society
  • Statement on Genetics and Life Insurance
  • Patenting of Human Gene Sequences and the EU Draft Directive
  • BSHG Statement on Patenting and Clinical Genetics

Canadian College of Medical Geneticists

  • Policy Statement Concerning DNA Banking and Molecular Genetic Diagnosis
  • China’s Eugenics Law: A Position Statement of the Canadian College of Medical Geneticists

Council of Europe (from Brody: The Ethics of Biomedical Research)

  • Recommendations Concerning Medical Research on Human Beings
  • Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine
  • Scientific Research and/or Experimentation on Human Gametes, Embryos and Fetuses and Donation of Such Human Material
  • Recommendations on Genetic Testing and Screening for Health Care Purposes

Council for International Organizations of Medical Sciences (CIOMS)

  • The Declaration of Inuyama
  • International Ethical Guidelines for Biomedical Research Involving Human Subjects (from Brody: The Ethics of Biomedical Research)

European Medical Research Council (from Brody: The Ethics of Biomedical Research

  • Gene Therapy in Man

European Society of Human Genetics

  • Quality Guidelines and Standards for Genetic Laboratories/Clinics in Prenatal Diagnosis on Fetal Samples Obtained by Invasive Procedures: An Attempt to Establish a Common European Framework for Quality Assessment
  • Chinese Amend Policy on Sterilization for Genetic Reasons (REFERENCES TWO DOCS NOT AT UW)

German Government (from Brody: The Ethics of Biomedical Research)

  • German Embryo Protection Law (1990)

German Society of Human Genetics (Committee for Public Relations and Ethical Issues)

  • Statement on Prenatal Paternity Testing
  • Statement of the German Society of Human Genetics
  • Statement on Prenatal Diagnosis and Termination of Pregnancy
  • Statement on the Discovery of the Breast Cancer Gene BRCA1
  • Statement on Genetic Diagnosis in Children and Adolescents
  • Statement on the Prenatal Diagnosis of Sex
  • Statement on Postnatal Predictive Genetic Diagnosis
  • Statement on Population Screening for Heterozygotes

Health Departments of the United Kingdom (Gene Therapy Committee)

  • Writing Information Leaflets for Patients Participating in Gene Therapy Research

Health Sciences Council of Japan (from Brody: The Ethics of Biomedical Research)

  • Guidelines for Gene Therapy Clinical Research

Human Genetics Advisory Commission (British Organization)

  • The Implications of Genetic Testing for Insurance
  • The Implications of Genetic Testing for Life Insurance
  • Cloning Issues in Reproduction, Science, and Medicine (January 1998)
  • Cloning Issues in Reproduction, Science, and Medicine (December 1998)

Human Genome Organization (HUGO)

  • HUGO Statement on the Patenting of DNA Sequences
  • HUGO Ethics Committee: Statement on DNA Sampling: Control and Access
  • Statement on the Principled Conduct of Genetics Research: HUGO Ethical, Legal, and Social Issues Committee Report to HUGO Council
  • Statement by Chair of the Ethics Committee of HUGO: Status, Sale, and Patenting of Human Genetic Material: An International Survey

18th International Congress of Genetics (Workshop on the Science and Ethics of Eugenics)

  • 18th International Congress of Genetics Statement on Eugenics (Summary)

King’s Fund Forum (London)

  • Consensus Statement: Screening for Fetal and Genetic Abnormality

Nuffield Council on Bioethics

  • Genetically Modified Crops: the Social and Ethical Issues
  • Mental Disorders and Genetics: the Ethical Context (summary)
  • Human Tissue: Ethical and Legal Issues (summary)
  • Genetic Screening: Ethical Issues (summary)
  • Animal-to-Human Transplants: the Ethics of Xenotransplantation (summary)

UNESCO (United Nations) International Bioethics Committee

  • Universal Declaration on the Human Genome and Human Rights
  • Article: UNESCO, Genetics, and Human Rights
  • Report on Human Gene Therapy
  • Report on Genetic Screening and Testing

World Federation of Neurology (Research Committee Research Group on Huntington’s Chorea, with representatives from the International Huntington Association)

  • Ethical Issues Policy Statement on Huntington’s Disease Molecular Genetics Predictive Test
  • Guidelines for the Molecular Genetics Predictive Test in Huntington’s Disease

World Health Organization (WHO)

  • Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services
  • WHO NCD Essential Norms and Standards: Human Genetics (PRINTED A LIST: NEED TO FIND THEM…NOT ON WEBPAGE: EMAILED DR VICTOR BOULYJENKOV, RESPONSIBLE OFFICER FOR WHO’S HUMAN GENETICS DIVISION OF NONCOMMUNICABLE DISEASES REQUESTING ALL GENETICS DOCS 5/28/99)
  • WHO Human Genetics Programme Publications (1990-1997): PRINTED A LIST OF DOCUMENTS: NEED TO FIND THEM…NOT AT HGN WEBLINK)

World Medical Association (from Brody: The Ethics of Biomedical Research)

  • Statement on Fetal Tissue Transplantation
  • Declaration on the Human Genome Project

REGIONAL GENETICS

Council for Regional Genetics Networks (CORN)

  • Guidelines for Clinical Genetics Services for the Public’s Health
  • Guidelines for the Retention, Storage, and Use of Residual Dried Blood Spot Samples after Newborn Screening Analysis: Statement of the Council of Regional Networks for Genetic Services

New England Regional Genetics Group (NERGG)

  • Position Statement: Carrier Testing for Canavan Disease

Southeastern Regional Genetics Group (SERGG)

  • Position Statement on Interphase in Situ Hybridization Prenatal Diagnosis

STATE GENETICS

California Department of Health Services: Genetic Disease Branch

  • List of Published Journal Articles

Nebraska Health and Human Services: Newborn Screening Program

  • Nebraska Human Genetic Technology Commission Final Report
  • Top Ten Pitfalls in Newborn Screening

Vermont Human Genetics Initiative

  • The Community Ethics Project

Vermont Newborn Screening Program

  • Responsibility for Ensuring That the Newborn Screening Test is Performed
  • "Refusal to Consent" Form

FEDERAL GOVERNMENT

CDC

  • CDC Guidelines for Hereditary Hemochromatosis
  • Newborn Screening for Cystic Fibrosis: A Paradigm for Public Health Genetics Policy Development

CDC Genetics Working Group

  • From Genes to Public Health: The Applications of Genetic Technology in Disease Prevention

Centers for Disease Control (CDC) and National Human Genome Research Institute (NHGRI) expert panel

  • Consensus Statement: Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening

DOE Human Genome Program’s Human Genome News

  • Ethical Issues in Human Gene Therapy (LeRoy Walters)
  • Protecting Genetic Privacy: Why It is So Hard to DO (Mark Rothstein)
  • Genetics in the 21st Century (Eric Lander)
  • The Human Genome Project: Science, Law, and Social Change in the 21st Century: Reports from the Cambridge Symposium

Department of Health and Human Services

  • Statement on Genetic Discrimination by Donna Shalala, Secretary of Health and Human Services

Department of Health and Human Services and NIH

  • Guidelines for Research Involving Recombinant DNA Molecules
  • Recombinant DNA Research: Proposed Actions under Guidelines

FDA (Center for Biologics Evaluation and Research (CBER)

  • Points to Consider in Human Somatic Cell Therapy and Gene Therapy (1991)

National Cancer Institute

  • Confidentiality, Data Security, and Cancer Research: Perspectives from the National Cancer Institute

National Cancer Institute and National Center for Human Genome Research Workshop

  • Recommendations on Predictive Testing for Germ Line p53 Mutations Among Cancer-Prone Individuals

National Center for Human Genome Research (NCHGR) (from Brody: The Ethics of Biomedical Research)

  • Policy on Availability and Patenting of Human Genomic DNA Sequence Produced by NCHGR Pilot Projects

National Center for Human Genome Research (NCHGR)

  • NCHGR-DOE Guidance on Human Subjects Issues in Large-Scale DNA Sequencing

National Heart, Lung, and Blood Institute (NIH)

  • Report of the Special Emphasis Panel: Opportunities and Obstacles to Genetic Research in NHLBI Clinical Studies

National Human Genome Research Institute (NHGRI)

  • Policy Recommendations: Insurance Discrimination, Employment Discrimination, Privacy/Confidentiality
  • Genetic Information and the Workforce (by NHGRI, DHHS, EEOC, and Department of Justice)
  • Preparing Health Professionals for the Genetic Revolution (statement by Francis Collins)

National Human Genome Research Institute (NHGRI): Task Force and Workshop Reports

  • Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing (IN REFERENCE MANAGER, 180 pages!)
  • Genetic Testing for Cystic Fibrosis Consensus Development Conference Statement
  • Hereditary Hemochromatosis: Gene Discovery and Policy Meeting
  • Report of the Joint NIH/DOE Committee to Evaluate the Ethical, Legal, and Social Implications of the Human Genome Project
  • NIH-DOE ELSI Working Group and National Action Plan on Breast Cancer Workshop on Genetic Discrimination and the Workplace
  • NIH-DOE ELSI Working Group and National Action Plan on Breast Cancer Workshop on Genetic Discrimination and Health Insurance
  • Protecting Human Research Subjects: 1993 OPPR IRB Guidebook Chapter on Human Genetic Research
  • NIH Workshop Statement: Reproductive Genetic Testing: Impact on Women
  • NIH Workshop Statement: Population Screening for the CF Gene
  • Consensus Statement: The Clinical Introduction of Genetic Testing for Alzheimer Disease: An Ethical Perspective

National Institute on Aging (Alzheimer’s Association Working Group)

  • Consensus Statement: Apolipoprotein E Genotyping in Alzheimer’s Disease

NIH-funded Cancer Genetics Studies Consortium: Task Force on Informed Consent

  • Consensus Statement: Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent

NIH-funded Cancer Genetics Studies Consortium

  • Recommendations for Follow-up Care of Individuals with an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer
  • Recommendations for Follow-up Care of Individuals with an Inherited Predisposition to Cancer: II. BRCA1 and BRCAII

NIH-CDC Workshop

  • Consensus Statement: Informed Consent for Genetic Research on Stored Tissue Samples

NIH-DOE ELSI Working Group

  • The Bell Curve: Statement by the NIH-DOE Joint Working Group on the Ethical, Legal, and Social Implications of Human Genome Research

NIH-DOE ELSI Working Group: Task Force on Genetic Information and Insurance

  • Genetic Information and Health Insurance: Report of the Task Force on Genetic Information and Insurance

NIH-DOE ELSI Working Group and the National Action Plan on Breast Cancer (NAPBC)

  • Policy Forum: Genetic Information and the Workplace: Legislative Approaches and Policy Challenges
  • Government-Citizen Group Suggest Policies to Limit Genetic Discrimination in the Workplace
  • Genetic Discrimination and Health Insurance: An Urgent Need for Reform
  • Genetic Information and Health Insurance: State Legislative Approaches

Joint NIH/DOE Committee To Evaluate The Ethical, Legal, and Social Implications Program of the Human Genome Project

  • Full Report of the Joint NIH/DOE Committee To Evaluate The Ethical, Legal, and Social Implications Program of the Human Genome Project

NIH Human Embryo Research Panel (from Brody: The Ethics of Biomedical Research)

  • Report of the Human Embryo Research Panel (1994)

NIH (National Center for Human Genome Research)

National Advisory Council for Human Genome Research

  • Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk

The Hastings Center Project on Priorities in the Clinical Application of Human Genome Research

  • Special Communication: National Policy Development for the Clinical Application of Genetic Diagnostic Technologies: Lessons from Cystic Fibrosis

NIH (National Human Genome Research Institute)

  • Consensus Statement: The Clinical Introduction of Genetic Testing for Alzheimer Disease

NIH Office of Medical Applications of Research

  • Consensus Conference: Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies

NIH Recombinant DNA Advisory Committee (RAC)

  • Recombinant DNA Research: Request for Public Comment on "Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols": January 22, 1985
  • Amendments to Appendix M, The Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into the Genome of One or More Human Subjects
  • Recombinant DNA Research: Proposed Actions Under Guidelines
  • RAC Meeting Minutes: June 7-8, 1993
  • RAC Meeting Minutes: March 6-7, 1995
  • RAC Meeting Minutes: March 6-7, 1997
  • RAC Meeting Minutes: June 18-19, 1998
  • NIH Launches Discussion of In Utero Gene Therapy
  • RAC Confronts In Utero Gene Therapy Proposals

NIH Technology Assessment Panel on Gaucher Disease

  • Gaucher Disease: Current Issues in Diagnosis and Treatment

NIH Workshop on Population Screening for the Cystic Fibrosis Gene

  • Special Report: Statement from the National Institutes of Health Workshop on Population Screening for the Cystic Fibrosis Gene

National Institute of Mental Health (NIMH)

  • Genetics and Mental Disorders: Report of the NIMH Genetics Workgroup

National Performance Review (Clinton and Gore)

  • Reinventing the Regulation of Human Tissue (FDA)

National Research Council

  • NRC Oks Long-Delayed Survey of Human Genome Diversity
  • (Committee on DNA Forensic Science): The Evaluation of Forensic DNA Evidence (Excerpt from Executive Summary with recommendations)

Office for Protection from Research Risks (OPRR)

  • Human Subject Regulations Decision Charts
  • Privacy Protection for Research Subjects: "Certificates of Confidentiality"

Office of Technology Assessment

  • Genetic Screening and Monitoring in the Workplace : Chapter 1: Summary, Policy Issues, and Options for Congressional Action
  • Cystic Fibrosis: Chapter 1: Summary, Policy Issues, and Options for Congressional Action